ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,291.60
-0.46%
S&P ASX All Technology
3,857.40
0.03%
Brent Oil
73.315
0.14%
US Dollar vs AUD
1.57138
0.10%
Bitcoin
99,860.74
-0.20%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Oncotelic Therapeutics Inc (QB) (OTLC)

  7. Oncotelic Therapeutics Inc (QB) (OTLC) News

OTLC

Oncotelic Therapeutics (QB) (OTLC)

Oncotelic Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OTLC
DateTimeSourceHeadlineSymbolCompany
27/11/202403:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
20/11/202409:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/11/202409:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:OTLCOncotelic Therapeutics Inc (QB)
27/08/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
15/08/202402:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/02/202409:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
31/10/202300:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
24/08/202300:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
19/08/202307:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
13/07/202323:25Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
13/07/202323:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
30/06/202323:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
30/06/202323:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
21/06/202302:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
17/06/202302:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
31/05/202323:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
20/05/202306:45Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/05/202307:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
20/04/202320:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/04/202307:02Edgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/04/202320:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/03/202301:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
08/12/202200:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
26/11/202201:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
19/11/202209:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/11/202206:25Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
28/09/202223:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
29/08/202223:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
22/08/202222:32Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
16/08/202204:34Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:OTLC

Your Recent History

NYSE
MRK
Merck
ASX
RIO
Rio Tinto
FX
EURAUD
Euro vs AUD
ASX
BHP
BHP
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
ASX
WPL
Woodside Petroleum
FX
AUDCAD
AUD vs CAD
ASX
CSL
CSL
ASX
XJO
S&P ASX 200
FTSE
UKX
FTSE 100
COIN
DOGEUSD
Dogecoin
ASX
NAB
National Australia Bank
ASX
XAO
Australian SE All Ordina...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved